Skip to content
Abierto
Menu

Award notice

Safety Evaluation and Toxicology Studies and Related Services for Drug Development

75N95024D00022

National Institutes of Health, National Institutes of Health Nida. Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).

View on SAM.govMarkdown

Awarded

Mriglobal

$48,622,546.00 on the award notice, June 24, 2024, contract 75N95024D00022

Description

As published on SAM.gov.

This synopsis of contract award is published pursuant to FAR Subpart 5.3.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Mriglobal
UEI
HKQHNFKNKL15
CAGE
21165
Vendor location
Kansas City, MO
Contract
75N95024D00022
Obligated
$0.00, potential $48,622,546
Actions
4 between June 24, 2024 and March 5, 2025
Competition
Full and Open Competition, 6 offers received
Set-aside reported
No Set Aside Used.
Described as
Safety Evaluation and Toxicology Studies and Related Services for Drug Development
Match
award number 75N95024D00022 equals the contract number; same awarding office 75N950 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. August 13, 2024

    Award notice, originally solicitation

    Awarded to MRIGLOBAL Kansas City for $48,622,546. SAM.gov, notice 6dce5b932f8944a9afb26f5858211053

Points of contact

Also open from this buyer